Unlock stock picks and a broker-level newsfeed that powers Wall Street.

The Zacks Analyst Blog Highlights JPMorgan Chase, UnitedHealth, Verizon, Twin Disc and Sypris

In This Article:

For Immediate Release

Chicago, IL – December 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. JPM, UnitedHealth Group Inc. UNH, Verizon Communications Inc. VZ, Twin Disc, Inc. TWIN and Sypris Solutions, Inc. SYPR.

Here are highlights from Monday’s Analyst Blog:

Top Research Reports for JPMorgan, UnitedHealth and Verizon

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co., UnitedHealth Group Inc. and Verizon Communications Inc., as well as two micro-cap stocks Twin Disc, Inc. and Sypris Solutions, Inc. The Zacks microcap research is unique as our reseaarch content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of JPMorgan Chase have outperformed the Zacks Finance sector this year (+41% vs. +21%) as well as the S&P 500 index (+41% vs. +27.8%). Driving the momentum is the company's leverage to the steadily improving macroeconomic backdrop, characterized by optimism about the incoming administration's policy agenda and the ongoing monetary easing program.

According to the Zacks analyst estimates NII (managed) and total loans imply a CAGR of 1.2% and 5.2%, respectively, by 2026. A resurgence in deal-making activities and the company’s leading position in the investment banking (IB) business are expected to aid related fee income.

Yet, the volatile nature of the capital markets business and high mortgage rates will likely hurt fee income growth. Owing to these challenges, we expect non-interest income (managed) to rise in 2024 but decline next year. Mounting operating expenses will hamper the bottom line. We expect non-interest expenses to rise 5.5% in 2024.

(You can read the full research report on JPMorgan Chase here >>>)

UnitedHealth Group shares have modestly outperformed the Zacks Medical - HMOs industry over the past year (+1.3% vs. -3.8%), though the stock has been under pressure lately following the tragic headlines about its senior executive's murder in New York. The company’s top line remains poised for growth on the back of a strong market position, new deals, renewed agreements and expansion of service offerings. The company’s solid health services segment provides diversification benefits.